ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,687 | -27.1% | 5,627 | 0.0% | 0.00% | -40.0% |
Q2 2023 | $20,145 | +64.2% | 5,627 | 0.0% | 0.01% | +66.7% |
Q1 2023 | $12,267 | -81.9% | 5,627 | 0.0% | 0.00% | -82.4% |
Q4 2022 | $67,693 | +88.0% | 5,627 | 0.0% | 0.02% | +70.0% |
Q3 2022 | $36,000 | +38.5% | 5,627 | 0.0% | 0.01% | +42.9% |
Q2 2022 | $26,000 | -46.9% | 5,627 | 0.0% | 0.01% | -36.4% |
Q1 2022 | $49,000 | -38.8% | 5,627 | 0.0% | 0.01% | -31.2% |
Q4 2021 | $80,000 | -35.5% | 5,627 | 0.0% | 0.02% | -40.7% |
Q3 2021 | $124,000 | +65.3% | 5,627 | 0.0% | 0.03% | +68.8% |
Q2 2021 | $75,000 | +31.6% | 5,627 | 0.0% | 0.02% | +23.1% |
Q1 2021 | $57,000 | +137.5% | 5,627 | 0.0% | 0.01% | +116.7% |
Q4 2020 | $24,000 | +60.0% | 5,627 | 0.0% | 0.01% | +20.0% |
Q3 2020 | $15,000 | -25.0% | 5,627 | 0.0% | 0.01% | -28.6% |
Q2 2020 | $20,000 | +17.6% | 5,627 | 0.0% | 0.01% | -22.2% |
Q1 2020 | $17,000 | -41.4% | 5,627 | 0.0% | 0.01% | -35.7% |
Q4 2019 | $29,000 | +61.1% | 5,627 | 0.0% | 0.01% | +40.0% |
Q3 2019 | $18,000 | – | 5,627 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |